Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N.
Rapid correction of low vitamin D status in nursing home residents.
Osteoporos Int. 2008 Apr 18; [Epub ahead of print] Yendt ER, Kovacs KA, Jones G.
Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
Clin Endocrinol (Oxf). 2008 Apr 14; [Epub ahead of print] Fabian E, Elmadfa I.
Nutritional situation of the elderly in the European Union: data of the European Nutrition and Health Report (2004).
Ann Nutr Metab. 2008;52 Suppl 1:57-61. Epub 2008 Mar 7. Fritz K, Elmadfa I.
Quality of nutrition of elderly with different degrees of dependency: elderly living in private homes.
Ann Nutr Metab. 2008;52 Suppl 1:47-50. Epub 2008 Mar 7. Elmadfa I, Meyer AL.
Body composition, changing physiological functions and nutrient requirements of the elderly.
Ann Nutr Metab. 2008;52 Suppl 1:2-5. Epub 2008 Mar 7. Lanham-New SA.
Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment.
Proc Nutr Soc. 2008 May;67(2):163-76. Zhu K, Bruce D, Austin N, Devine A, Ebeling PR, Prince RL.
A Randomized Controlled Trial of the Effects of Calcium with or Without Vitamin D on Bone Structure and Bone Related Chemistry in Elderly Women with Vitamin D Insufficiency.
J Bone Miner Res. 2008 Apr 14; [Epub ahead of print] Holden JM, Lemar LE, Exler J.
Vitamin D in foods: development of the US Department of Agriculture database.
Am J Clin Nutr. 2008 Apr;87(4):1092S-6S. Zerwekh JE.
Blood biomarkers of vitamin D status.
Am J Clin Nutr. 2008 Apr;87(4):1087S-91S. Pasch A, Frey FJ, Eisenberger U, Mohaupt MG, Bonny O.
PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.
Nephrol Dial Transplant. 2008 Apr 8; [Epub ahead of print] Hafner V, Rutsch C, Ding R, Heinrich T, Diedrichs L, Schmidt-Gayk H, Walter-Sack I, Bommer J, Mikus G.
Calcium balance during calcitriol and paricalcitol administration in healthy humans.
Int J Clin Pharmacol Ther. 2008 Mar;46(3):131-5. Uenishi K, Ishida H, Nakamura K.
Development of a simple food frequency questionnaire to estimate intakes of calcium and other nutrients for the prevention and management of osteoporosis.
J Nutr Sci Vitaminol (Tokyo). 2008 Feb;54(1):25-9. Dawson-Hughes B, Bischoff-Ferrari HA.
Therapy of osteoporosis with calcium and vitamin D.
J Bone Miner Res. 2007 Dec;22 Suppl 2:V59-63. Tsironi E, Hadjidakis D, Mallas E, Tzathas C, Karamanolis DG, Ladas SD.
Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients.
J Musculoskelet Neuronal Interact. 2008 Jan-Mar;8(1):79-84.

Kim HW, Kang E, Im S, Ko YJ, Im SA, Lee JI.
Prevalence of pre-stroke low bone mineral density and vertebral fracture in first stroke patients.
Bone. 2008 Mar 7; [Epub ahead of print] Larkin A, Sheahan N, O'Connor U, Gray L, Dowling A, Vano E, Torbica P, Salat D, Schreiner A, Neofotistou V, Malone JF.
QA/ACCEPTANCE TESTING OF DEXA X-RAY SYSTEMS USED IN BONE MINERAL DENSITOMETRY.
Radiat Prot Dosimetry. 2008 Apr 1; [Epub ahead of print] Omodei U, Benussi C, Ramazzotto F, Feller M, Gambacciani M.
Risk Identification of Osteoporosis in Postmenopausal Women by a Simple Algorithm Based on Ultrasound Densitometry and Body Mass Index.
J Clin Densitom. 2008 Mar 27; [Epub ahead of print] Iwaniec UT, Wronski TJ, Turner RT.
Histological analysis of bone.
Methods Mol Biol. 2008;447:325-41. Mazzaglia PJ, Berber E, Kovach A, Milas M, Esselstyn C, Siperstein AE.
The changing presentation of hyperparathyroidism over 3 decades.
Arch Surg. 2008 Mar;143(3):260-6. Daly RM, Petrass N, Bass S, Nowson CA.
The skeletal benefits of calcium- and vitamin D3-fortified milk are sustained in older men after withdrawal of supplementation: an 18-mo follow-up study.
Am J Clin Nutr. 2008 Mar;87(3):771-7. Brink E, Coxam V, Robins S, Wahala K, Cassidy A, Branca F; PHYTOS Investigators.
Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study.
Am J Clin Nutr. 2008 Mar;87(3):761-70. Lorente MD, Marginet C, Pujante P.
Osteoporosis: diagnosis or sign of suspicion?]
Rev Med Univ Navarra. 2007 Oct-Dec;51(4):9-11. Spanish. Geusens P, Dumitrescu B, van Geel T, van Helden S, Vanhoof J, Jan Dinant G.
Impact of Systematic Implementation of a Clinical Case Finding Strategy on Diagnosis and Therapy of Postmenopausal Osteoporosis.
J Bone Miner Res. 2008 Feb 5; [Epub ahead of print] Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA, Morrish DW, Maksymowych WP, Rowe BH.
Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial.
CMAJ. 2008 Feb 26;178(5):569-75. Gloth FM 3rd, Simonson W.
Osteoporosis is underdiagnosed in skilled nursing facilities: a large-scale heel BMD screening study.
J Am Med Dir Assoc. 2008 Mar;9(3):190-3. Vasikaran SD.
Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis.
Crit Rev Clin Lab Sci. 2008;45(2):221-58. Coxam V.
Phyto-oestrogens and bone health.
Proc Nutr Soc. 2008 May;67(2):184-95. Eastell R, Hannon RA.
Biomarkers of bone health and osteoporosis risk.
Proc Nutr Soc. 2008 May;67(2):157-162.

Sebba AI.
Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.
Clin Ther. 2008 Mar;30(3):443-52. Guney E, Kisakol G, Ozgen AG, Yilmaz C, Kabalak T.
Effects of bisphosphonates on lipid metabolism.
Neuro Endocrinol Lett. 2008 Apr 11;29(2) [Epub ahead of print] Grewal VS, Fayans EP.
Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management.
N Y State Dent J. 2008 Jan;74(1):38-44. Tucci JR.
Effect of inappropriate and continuous therapy with alendronate for ten years on skeletal integrity - observations in two elderly patients.
J Endocrinol Invest. 2008 Mar;31(3):251-4. Geusens PP, Roux CH, Reid DM, Lems WF, Adami S, Adachi JD, Sambrook PN, Saag KG, Lane NE, Hochberg MC; Medscape.
Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence-based clinical perspective.
Nat Clin Pract Rheumatol. 2008 Apr 8; [Epub ahead of print] Bischoff-Ferrari HA, Papapoulos SE, de Papp AE, West JA.
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion.
Curr Med Res Opin. 2008 Apr 2; [Epub ahead of print] Delmas PD.
Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases.
J Clin Densitom. 2008 Mar 27; [Epub ahead of print] Choi BG, Vilahur G, Zafar MU, Cardoso L, Yadegar D, Ibanez B, Tunstead J, Viles-Gonzalez JF, Schaffler MB, Fuster V, Badimon JJ.
Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model.
Atherosclerosis. 2008 Feb 21; [Epub ahead of print] Brufsky AM.
Bone health issues in women with early-stage breast cancer receiving aromatase inhibitors.
Curr Oncol Rep. 2008 Jan;10(1):18-26. Review. Fast S, Bonnema SJ, Hegedas L.
The majority of Danish non-toxic goitre patients are ineligible for Levothyroxine suppressive therapy.
Clin Endocrinol (Oxf). 2008 Mar 15; [Epub ahead of print] Dannemann C, Grätz KW, Zwahlen RA.
[Bisphosphonate-induced osteonecrosis of the jaws--a guide to diagnosis, therapy and prevention of BON in dental practice]
Schweiz Monatsschr Zahnmed. 2008;118(2):113-23. French, German. Grey A, Reid IR.
Differences between the bisphosphonates for the prevention and treatment of osteoporosis.
Ther Clin Risk Manag. 2006 Mar;2(1):77-86. Wessel JH, Dodson TB, Zavras AI.
Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study.
J Oral Maxillofac Surg. 2008 Apr;66(4):625-31. [No authors listed]
Ibandronic acid: new drug. Osteoporosis: one tablet a month, but risk of a 'flu-like' syndrome.
Prescrire Int. 2008 Feb;17(93):11.